bf/NASDAQ:BVXV_icon.png

NASDAQ:BVXV

BiondVax Pharmaceuticals Ltd.

  • Stock

USD

Last Close

1.35

06/09 19:59

Market Cap

4.97M

Beta: 2.47

Volume Today

22.67K

Avg: 41.50K

PE Ratio

0.59

PFCF: −3.53

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-7.76M
-
-10.20M
31.36%
-9.18M
9.95%
-34.55M
276.21%
-87.73M
153.91%
-109.19M
24.47%
-4.46M
95.92%
-39.98M
797.37%
-5.80M
85.50%
depreciation and amortization
677K
-
628K
7.24%
621K
1.11%
440K
29.15%
260K
40.91%
1.65M
532.69%
2.44M
48.09%
2.42M
0.86%
562K
76.73%
deferred income tax
59K
-
2K
96.61%
42K
2,000%
-53K
226.19%
51K
196.23%
-122K
339.22%
-37K
69.67%
-33K
10.81%
stock based compensation
363K
-
745K
105.23%
1.26M
69.26%
519K
58.84%
260K
49.90%
3.68M
1,316.92%
9.47M
157.11%
8.90M
6.00%
1.60M
82.01%
change in working capital
-529K
-
-339K
35.92%
323K
195.28%
2.40M
643.03%
31.42M
1,209.13%
11.03M
64.90%
-92.73M
940.98%
5.18M
105.58%
271K
94.77%
accounts receivables
inventory
accounts payables
132K
-
415K
214.39%
-238K
157.35%
5.54M
2,426.47%
14.50M
161.87%
-3.66M
125.25%
-15.19M
315.02%
1.24M
108.15%
-175K
114.12%
other working capital
-661K
-
-754K
14.07%
561K
174.40%
-3.14M
659.18%
16.92M
639.34%
14.69M
13.19%
-77.54M
627.92%
3.94M
105.08%
446K
88.68%
other non cash items
-319K
-
-1.10M
245.45%
-2.67M
142.65%
21.14M
890.65%
-1.46M
106.89%
15.90M
1,192.17%
12.78M
19.63%
-970K
107.59%
-3.90M
302.47%
net cash provided by operating activities
-7.57M
-
-10.27M
35.59%
-9.65M
5.98%
-10.05M
4.11%
-57.19M
469.08%
-77.06M
34.73%
-72.54M
5.86%
-24.48M
66.25%
-7.26M
70.33%
investments in property plant and equipment
-30K
-
-34K
13.33%
-20K
41.18%
-4.51M
22,440%
-23.73M
426.42%
-7.43M
68.69%
-6.13M
17.46%
-430K
92.99%
-836K
94.42%
acquisitions net
purchases of investments
sales maturities of investments
4.07M
-
other investing activites
-150K
-
-9K
94%
-7.79M
86,488.89%
7.20M
192.39%
277K
96.15%
230K
16.97%
197K
14.35%
69K
64.97%
net cash used for investing activites
-180K
-
-43K
76.11%
-7.81M
18,069.77%
6.76M
186.51%
-23.45M
447.00%
-7.20M
69.31%
-5.93M
17.56%
-361K
93.92%
-836K
131.58%
debt repayment
-581K
-
-1.24M
113.43%
-1.22M
1.61%
common stock issued
27.32M
-
55.69M
-
70.27M
-
69.00M
-
932K
98.65%
common stock repurchased
dividends paid
other financing activites
-782K
-
6.43M
922.25%
6.15M
-
84.32M
1,271.74%
15.53M
81.59%
14.96M
3.67%
5.84M
-
net cash used provided by financing activities
-782K
-
33.75M
4,416.24%
61.84M
-
84.32M
36.36%
85.21M
1.06%
13.72M
83.90%
67.78M
394.19%
6.78M
90.00%
effect of forex changes on cash
283K
-
415K
46.64%
-299K
172.05%
-2.87M
860.20%
827K
128.81%
-4.37M
628.78%
1.71M
139.15%
1.68M
2.04%
-1.98M
217.89%
net change in cash
-8.25M
-
23.86M
389.15%
-17.77M
174.46%
55.68M
413.41%
4.50M
91.92%
-3.42M
175.89%
-63.05M
1,745.61%
44.62M
170.77%
-3.30M
107.40%
cash at beginning of period
17.86M
-
9.61M
46.19%
33.47M
248.21%
15.71M
53.08%
71.38M
354.52%
75.88M
6.31%
72.47M
4.50%
9.42M
87.00%
17.52M
85.94%
cash at end of period
9.61M
-
33.47M
248.21%
15.71M
53.08%
71.38M
354.52%
75.88M
6.31%
72.47M
4.50%
9.42M
87.00%
54.04M
473.57%
14.21M
73.69%
operating cash flow
-7.57M
-
-10.27M
35.59%
-9.65M
5.98%
-10.05M
4.11%
-57.19M
469.08%
-77.06M
34.73%
-72.54M
5.86%
-24.48M
66.25%
-7.26M
70.33%
capital expenditure
-30K
-
-34K
13.33%
-20K
41.18%
-4.51M
22,440%
-23.73M
426.42%
-7.43M
68.69%
-6.13M
17.46%
-430K
92.99%
-836K
94.42%
free cash flow
-7.60M
-
-10.30M
35.50%
-9.67M
6.10%
-14.56M
50.50%
-80.92M
455.87%
-84.49M
4.40%
-78.67M
6.88%
-24.91M
68.33%
-8.10M
67.48%

All numbers in USD (except ratios and percentages)